UFP Technologies, Inc.

UFPT ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $9.2M $8.0M $7.6M $7.6M $11.3M $10.9M $10.8M $9.4M
Depreciation & Amortization $5.6M $5.6M $4.8M $4.4M $4.1M $2.9M $2.8M $3.2M
Depreciation — — — — — — — —
Amortization $300.0K $300.0K $318.0K $393.0K $393.0K $478.0K $195.0K $223.9K
Stock-Based Compensation $1.1M $1.1M $1.1M $1.1M $924.0K $860.0K $1.1M $963.7K
Net Cash from Operating Activities $17.5M $9.3M $12.5M $11.1M $16.1M $16.2M $11.7M $11.8M
Investing Activities
Capital Expenditures $10.4M $7.2M $15.7M $13.4M $5.8M $12.0M $3.7M $3.3M
Business Acquisitions — — — — — $3.6M — —
Net Cash from Investing Activities $-10.4M $-7.2M $-15.7M — — — — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — $587.0K — — — — —
Net Cash from Financing Activities $-475.0K $-559.0K $-1.1M — — — — —
Net Change in Cash $6.6M $1.6M $-4.2M — — — — —
Free Cash Flow $7.1M $2.1M $-3.2M $-2.3M $10.3M $4.2M $8.0M $8.5M
← Newer Page 2 of 3 Older →